28987-47-5Relevant articles and documents
Design and Synthesis of Highly Active Peroxisome Proliferator-Activated Receptor (PPAR) β/δ Inverse Agonists with Prolonged Cellular Activity
Toth, Philipp M.,Lieber, Sonja,Scheer, Frithjof M.,Schumann, Tim,Schober, Yvonne,Nockher, Wolfgang A.,Adhikary, Till,Müller-Brüsselbach, Sabine,Müller, Rolf,Diederich, Wibke E.
supporting information, p. 488 - 496 (2016/03/12)
Based on 3-(((4-(hexylamino)-2-methoxyphenyl)amino)sulfonyl)-2-thiophenecarboxylic acid methyl ester (ST247, compound 2), a recently described peroxisome proliferator-activated receptor (PPAR)β/δ-selective inverse agonist, we designed and synthesized a se
Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)
Han, Young Taek,Kim, Kyeojin,Choi, Gyeong-In,An, Hongchan,Son, Dohyun,Kim, Hee,Ha, Hee-Jin,Son, Jun-Hyeng,Chung, Suk-Jae,Park, Hyun-Ju,Lee, Jeewoo,Suh, Young-Ger
, p. 128 - 142 (2014/05/06)
In an effort to develop novel inhibitors of receptor for advanced glycation end products (RAGE) for the treatment of Alzheimer's disease, a series of pyrazole-5-carboxamides were designed, synthesized and biologically evaluated. Analyses of the extensive